Last reviewed · How we verify
Buserelin and Pregnyl
Buserelin and Pregnyl is a Small molecule drug developed by Regionshospitalet Viborg, Skive. It is currently FDA-approved.
At a glance
| Generic name | Buserelin and Pregnyl |
|---|---|
| Sponsor | Regionshospitalet Viborg, Skive |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve (NA)
- Dual Trigger" in IVF Patients at High Risk of Ovarian Hyper Stimulation Syndrome (PHASE4)
- Anti-Müllerian Hormone (AMH) Measured With Fully Automated Assay Versus AFC in the Prediction of Ovarian Response
- Co Administration of GnRH Agonist and hCG for Final Oocyte Maturation (PHASE4)
- The Exogenous Progesterone Free Luteal Phase After GnRHa Trigger - a Pilot Study in Normo-responder IVF Patients (PHASE4)
- Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles (PHASE4)
- Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist (PHASE4)
- Replacement of Fresh Embryo Transfers (ETs) by Frozen Embryo Transfers (FETs) Using Vitrification (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Buserelin and Pregnyl CI brief — competitive landscape report
- Buserelin and Pregnyl updates RSS · CI watch RSS
- Regionshospitalet Viborg, Skive portfolio CI
Frequently asked questions about Buserelin and Pregnyl
What is Buserelin and Pregnyl?
Buserelin and Pregnyl is a Small molecule drug developed by Regionshospitalet Viborg, Skive.
Who makes Buserelin and Pregnyl?
Buserelin and Pregnyl is developed and marketed by Regionshospitalet Viborg, Skive (see full Regionshospitalet Viborg, Skive pipeline at /company/regionshospitalet-viborg-skive).
What development phase is Buserelin and Pregnyl in?
Buserelin and Pregnyl is FDA-approved (marketed).
Related
- Manufacturer: Regionshospitalet Viborg, Skive — full pipeline
- Compare: Buserelin and Pregnyl vs similar drugs
- Pricing: Buserelin and Pregnyl cost, discount & access